Home » Topics » Regulatory

Regulatory
RSS

IND submitted for salmon calcitonin as oral osteoporosis treatment

Jan. 9, 2001

Marketing agreement with Bioglan for Solaraze expanded by SkyePharma

Jan. 8, 2001

U.K. MCA grants marketing clearance for Periostat tablets

Jan. 5, 2001

Major advances in infertility treatment announced by Serono

Jan. 5, 2001

Remicade is first drug approved for inhibiting progression of joint damage in RA

Jan. 3, 2001

New use claimed by Sanofi-Synthelabo for succinic acid derivatives

Dec. 21, 2000

GABA analogues reported to modulate substance P

Dec. 21, 2000

Questcor arranges Asian marketing agreement for metoclopramide nasal spray

Dec. 21, 2000

Vivus granted third PDE inhibitor patent

Dec. 21, 2000

Improved compositions of LHRH or somatostatin analogues described in recent patent

Dec. 20, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.